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Abstract Regucalcin (RGN/SMP30) was originally dis-
covered in 1978 as a calcium-binding protein that does not
contain the EF-hand motif of as a calcium-binding domain.
The name, regucalcin, was proposed for this calcium-
binding protein, which can regulate various Ca2?-depen-
dent enzymes activation in liver cells. The regucalcin gene
is localized on the X chromosome, and its expression is
mediated through many signaling factors. Regucalcin plays
a pivotal role in regulation of intracellular calcium
homeostasis in various cell types. Regucalcin also has a
suppressive effect on various signaling pathways from the
cytoplasm to nucleus in proliferating cells and regulates
nuclear function in including deoxyribonucleic acid (DNA)
and ribonucleic acid (RNA) synthesis. Overexpression of
endogenous regucalcin was found to suppress apoptosis in
modeled rat hepatoma cells and normal rat kidney proximal
epithelial NRK52 cells induced by various signaling fac-
tors. Suppressive effect of regucalcin on apoptosis is rela-
ted to inhibition of nuclear Ca2?-activated DNA
fragmentation, Ca2?/calmodulin-dependent nitric oxide
synthase, caspase-3, Bax, cytochrome C, protein tyrosine
kinase, protein tyrosine phosphatase in the cytoplasm and
nucleus. Moreover, regucalcin stimulates Bcl-2 mRNA
expression and depresses enhancement of caspase-3, Apaf-1
and Akt-1 mRNAs expression. This review discusses that
regucalcin plays a pivotal role in rescue of apoptotic cell
death, which is mediated through various signaling factors.
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Introduction
Regucalcin was discovered in 1978 as a calcium-binding
protein that does not contain the EF-hand motif of as a
calcium-binding domain [1–5]. The name, regucalcin, was
proposed for this calcium-binding protein, which regulates
various Ca2?- or Ca2?/calmodulin-dependent enzymes
activation in liver cells [4, 5]. Regucalcin (RGN) and its
gene (rgn) are identified in over 15 species consisting of
regucalcin family [6–8]. Regucalcin is highly conserved in
vertebrate species throughout evolution [6]. The regucalcin
gene is localized on the X chromosome and its organization
consists of seven exons and six introns [9–11]. The regu-
calcin gene expression is enhanced through calcium and
other signaling factors; AP-1, NF1-A1, RGPR-p117 and
b-catenin are identified as a transcription factor that enhances
transcription activity [8]. Regucalcin mRNA expression
and its protein content are pronounced in the liver and
kidney cortex of rats, although it is also expressed in other
tissues and cell types [12–14]. The protein named as
senesence marker protein-30 (SMP30), which is identical
to regucalcin, was also reported after discovery of regu-
calcin [15, 16].
Regucalcin plays a multifunctional role in cell regula-
tion; maintaining of intracellular calcium homeostasis in
many cell types, suppressions of various signaling path-
ways from the cytoplasm to nucleus in proliferating cells,
and regulation of nuclear functions including DNA and
RNA synthesis [5, 14, 17–19]. Regucalcin has also been
shown to suppress protein synthesis and activate proteases,
suggesting an involvement in protein turnover in cells [20,
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21]. Thus, regucalcin plays a multifunctional role in cell
regulation.
There is growing evidence that overexpression of
endogenous regucalcin suppresses apoptosis in modeled
liver (rat hepatoma H4-II-E) cells and normal rat kidney
proximal epithelial NRK52E cells that are induced through
various signaling factors. Regucalcin may play an impor-
tant role in rescue of apoptotic cell death. This review has
been written to outline the recent advances that have been
made concerning a suppressive role of regucalcin in the
regulation of apoptosis and will discuss the mechanism by
which regucalcin suppresses apoptosis.
Regucalcin suppresses apoptosis in modeled liver cells
Regucalcin inhibits apoptosis-related NO synthase
activity
NO may be important as a signaling factor in many cells
[22], and it plays a role in apoptosis of hepatoma cells [23].
NO mediates apoptosis by D-galactosamine in a primary
culture of rat hepatocytes [24]. Regucalcin has a suppres-
sive effect on Ca2?/calmodulin-dependent NO synthase
activity in the cloned rat hepatoma H4-II-E cells [25],
suggesting its role in apoptosis [25]. Suppressive effect of
regucalcin on NO synthase activity was also seen in pres-
ence of trifluoperazin (TFP), an inhibitor of calmodulin, or
ethyleneglycol bis (2-amino-ethylether)-N, N, N0, N0-tetra-
acetic acid (EGTA), a chelator of Ca2? [25]. Regucalcin
may have a suppressive effect on NO synthase activity due
to binding calmodulin and/or enzyme independently on
Ca2? in proliferating cells.
The role of endogenous regucalcin in cell regulation has
been shown in regucalcin/pCXN2-transfected hepatoma
H4-II-E cells that overexpress regucalcin stably [26]. The
regucalcin content of regucalcin/pCXN2-transfected cells
used in this study was 19.7-fold as compared with that of
the parental wild-type H4-II-E cells and pCXN2 vector-
transfected cells (mock type) [26]. Overexpressing of
endogenous regucalcin has also shown to have a suppres-
sive effect on NO synthase activity in H4-II-E cells
(transfectants) [25]. This decrease was completely abol-
ished in presence of anti-regucalcin monoclonal antibody
in the reaction mixture [25]. Moreover, the effect of Ca2?/
calmodulin addition in increasing NO synthase activity in
H4-II-E cells (wild-type) was also depressed in transfec-
tants [25]. Endogenous regucalcin may have a suppressive
effect on Ca2?/calmodulin-dependent NO synthase activity
in H4-II-E cells. Moreover, NO synthase activity was
enhanced in H4-II-E cells cultured with 10 % FBS as
compared with that of 1 % FBS [25]. Increase of NO
synthase activity in H4-II-E cells cultured with 10 % FBS
was enhanced in presence of anti-regucalcin monoclonal
antibody [25], supporting the view that endogenous regu-
calcin reveals a suppressive effect on enhancement of NO
synthase activity in proliferating cells.
A high concentration of NO, which is produced from
inducible NO synthase, has been shown to suppress cell
proliferation [27] and induce cell apoptosis [28]. It has
been reported that a low concentration of NO, which is
produced by endothelial NO synthase, protects against
cytotoxic effects of reaction oxygen species in cells [29].
Whether endogenous regucalcin suppresses NO production
in H4-II-E cells is unknown at present, although it inhibites
NO synthase activity [25]. It is speculated, however, that
regucalcin depresses NO production in H4-II-E cells.
Endogenous regucalcin may have the anti-apoptotic effect
due to suppressing NO production in hepatoma cells.
Regucalcin suppresses tumor necrosis factor a
(TNF-a)-induced apoptosis
TNF-a and NO mediate apoptosis induced by D-galctos-
amine in a primary culture of rat hepatocytes [27, 28].
TNF-a induces apoptosis in mammary adenocarcinoma
cells by an increase in intranuclear free Ca2? concentration
and DNA fragmentation [27]. When subconfluent H4-II-E
cells were cultured in a medium without FBS in the pres-
ence of TNF-a, TNF-a (0.1–10 ng/ml) caused a significant
decrease in the number of H4-II-E cells (wild-type),
inducing cell death. Overexpressing of regucalcin in H4-II-
E cells (transfectants) has been found to prevent the effect
of TNF-a in decreasing cell number [30]. Thus, over-
expressing of regucalcin has a rescue effect on cell death
induced with the higher concentration of TNF-a (10 ng/ml),
supporting the view that regucalcin has a suppressive effect
on TNF-a-induced cell death [30].
Culture with Nx-nitro-L-arginine methylester (NAME),
an inhibitor of NO synthase, has been shown to have a
suppressive effect on TNF-a-induced cell death [30].
Regucalcin inhibited Ca2?/calmodulin-dependent NO
synthase activity in H4-II-E cells [30]. Suppressive effect
of regucalcin on cell death may be partly resulted from the
depression of NO production enhanced after TNF-a stim-
ulation in H4-II-E cells. The effect of caspase inhibitor on
TNF-a-mediated cell death in H4-II-E cells has also been
shown [30]. TNF-a-induced cell death was depressed after
culture with caspase inhibitor in wild-type cells and
transfectants [30], suggesting that TNF-a-induced cell
death is partly involved activation of caspases in H4-II-E
cells. Regucalcin may have a suppressive effect on acti-
vation of caspases in the cells.
Moreover, overexpression of regucalcin has been shown
to have a suppressive effect on TNF-a-induced apoptosis in
human hepatoma HepG2 cells [31]. Akt, which is a
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survival factor in cells, has been shown to activate in
transfectants [31].
Interestingly, the effect of TNF-a in inducing apoptosis
has been shown to enhance in the hepatocytes obtained
from regucalcin-deficiency mice in vivo [32]. Moreover,
this animal was found to enhance liver injury after treat-
ment with anti-Fas antibody [32]. Regucalcin may play a
protective role on apoptosis in vivo.
Regucalcin suppresses lipopolysacharide (LPS)-
induced apoptosis
LPS induces cell apoptosis [33, 34]. LPS causes a decrease
in the number of H4-II-E cells (wild-type), inducing cell
death and apoptosis [35]. This decrease was completely
protected by overexpressing of endogenous regucalcin with
culture for 12–48 h [35]. Thus, overexpression of endog-
enous regucalcin has suppressive effects on LPS-stimulated
cell death and apoptosis.
LPS modulates the expression of a large number of
genes that favor apoptosis of fibroblastic cells, which are
dependent upon activation of caspase-8 [33]. There is
evidence that LPS-induced cell death is mediated through
accumulation of reactive oxygen species and activation of
p38 in rat brain cortex and hippocampus [33]. Culture with
LPS caused a significant decrease in Ca2?/calmodulin-
dependent NO synthase activity in H4-II-E (wild-type)
cells [35]. LPS-induced decrease in NO synthase activity
was preventeed in transfectants overexpressing regucalcin
[35]. LPS-induced cell death may be not resulted from NO
production in hepatoma cells, and suppressive effect of
regucalcin on LPS-induced cell death may be not involved
in NO in the cells. Moreover, LPS-induced cell death was
protected after culture with caspase-3 inhibitor [35].
Depressive effect of regucalcin on LPS-induced cell death
may be partly related to its inhibitory effect on caspase-3 in
hepatoma cells.
Regucalcin suppresses various signaling inhibitors-
induced apoptosis
An induction of apoptosis is partly mediated through
pathway of protein kinase. The death of H4-II-E cells
(wild-type) has been found to be induced after culture with
PD 98059, a ERK inhibitor, dibucaine, an inhibitor of
Ca2?-dependent protein kinase, or staurosporine, a potent
inhibitor of protein serine/threonin kinases (protein kinase
C), suggesting that various inhibitors-induced cell death is
partly involved in inhibition of protein kinases [35].
Overexpression of regucalcin rescued death of H4-II-E
cells cultured with PD 98059 or dibucaine [35]. This effect
was not observed after culture with staurosporine. PD
98059 induces apoptosis that is mediated through
inactivation of Bcl-2 due to increasing in phosphorylated
Bcl-2 in human prostate cancer cells [36]. Dibucaine has
been shown to activate various caspases, such as caspase-3,
-6, -8, and -9 (-like) activities, but not caspase-1 (-like)
activity, and induce mitochondrial membrane depolariza-
tion and release of cytochrome C from mitochondria into
the cytosol in leukemia cells (HL-60) [37]. Staurosporine
induces apoptosis in Chang liver cells through a mito-
chondria-caspase-dependent pathway, which is closely
correlated to a decrease in Bcl-2 and Bcl-XL levels in
cancer cells [38]. Regucalcin may partly suppress inacti-
vation of Bcl-2 or activation of caspases that are the
mechanism by which PD 98059 or dibucaine induces
apoptosis [38].
Regucalcin suppresses Ca2?-stimulated DNA
fragmentation
Apotosis is evoked by nuclear DNA fragmentation that is
mediated through activation of endonuclease. Isolated rat
liver nucleus contains a DNA endonuclease activity
dependent upon Ca2?, and Ca2? results in extensive DNA
hydrolysis [39]. Ca2? dependence of DNA fragmentation
process is based on increased DNA endonuclease activity
dependent upon sub-micromolar Ca2? when the nucleus is
reconstituted with NAD? and ATP [39]. This endonuclease
activity may be responsible for DNA fragmentation
occurring during programmed cell death (apoptosis) and
certain forms of chemically induced cell killing [39, 40].
Regucalcin has been found to have a suppressive effect
on Ca2?-activated DNA fragmentation in isolated rat liver
nuclei [41]. Among various metals, Ca2? was shown to
uniquely stimulate in vitro DNA fragmentation in isolated
rat liver nuclei [41]. This increase was seen after addition
of 1.0 lM Ca2?, in agreement with previous work [39, 41].
Presence of regucalcin (0.5-2.0 lM) in reaction mixture
evoked a complete suppression of activation of liver
nuclear DNA fragmentation, when 10 lM Ca2? was added
into the reaction mixture. This inhibition was not seen in
the presence of Ca2? at 25 or 50 lM. Thus, regucalcin has
been shown to have an inhibitory effect on DNA frag-
mentation with a comparatively lower concentration of
Ca2? (5.0 and 10 lM) [41]. Suppressive effect of regu-
calcin on nuclear DNA fragmentation may be partly based
on binding of Ca2?.
DNA fragmentation in rat liver nucleus has been
reported to be stimulated through Ca2?-calmodulin [39],
which exists in the nuclei [42]. Addition of calmodulin (10
and 20 lg/ml) in the reaction mixture did not enhance
nuclear Ca2? (10 lM)-activated DNA fragmentation [41];
however, nuclear endogenous calmodulin may enhance
Ca2?-activated DNA fragmentation. Regucalcin suppresses
nuclear DNA fragmentation in the presence or absence of
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exogenous calmodulin and Ca2? [41]. Regucalcin may
directly suppress endonucleas activity in the liver nuclei.
Ca2? plays an important role in the regulation of nuclear
functions [43, 44]. A sustained increase in cytosolic Ca2?
level precedes the activation of DNA fragmentation that is
characteristic of programmed cell death (apoptosis) and in
certain forms of chemically induced cell killing [39, 40].
Finding, that regucalcin depresses activation of nuclear
Ca2?-induced DNA fragmentation, suggests a role of reg-
ucalcin in regulation of apotosis.
Regucalcin suppresses on calcium signaling-induced
apoptosis
Calcium channel blockers, the endoplasmic reticulum
Ca2?-ATPase inghibitor thapsigargin and calcium iono-
phores are potent to lead several cell types to apoptosis [45,
46]. Thapasigargin is an inhibitor of Ca2?-ATPase in the
endoplasmic reticulum (Ca2? store) in cells, and treatment
with thapsigargin causes an elevation of sustained Ca2?
concentration in cells and induces apoptosis in hepatoma
cells [47]. Experiments on the nucleus isolated from cells
clearly demonstrate the induction of Ca2?-dependent
endonuclease activity during triggering apoptosis events
[47]. Rises in intracellular Ca2? concentration activates
endonuclease that mediates DNA cleavages into oligonu-
cleosome fragments [48]. Regucalcin has been shown to
have an inhibitory effect on Ca2?-activated DNA frag-
mentation in isolated rat liver nucleus [41].
Thapsigargin-induced DNA fragmentation in the hepa-
toma cells is not altered after culture with caspase inhibitor,
suggesting that thapsigargin-mediated apoptosis is inde-
pendent on activation of caspases [48]. Overexpression of
regucalcin in hepatoma cells suppresses thapsigargin-
induced DNA fragmentation [36]. This effect is not further
enhanced after culture with caspase inhibitor [36]. Pre-
sumably, regucalcin has a suppressive effect on thapsi-
gargin-mediated cell death due to protecting rise in
intracellular Ca2? concentration in hepatoma cells. Regu-
calcin has been shown to maintain intracellular Ca2?
homeostasis due to activating Ca2? pum enzymes in the
plasma membranes, mitochondria, and endoplasmic retic-
ulum of rat liver cells [17, 18].
Calcium entry into cells induces cell death [36, 49].
Culture with Bay K 8644, an antagonist of Ca2? entry in
cells, caused a significant increase in the death of hepatoma
H4-II-E cells (wild-type) [41]. Culture with Bay K 8644
did not cause cell death of H4-II-E cells overexpressing
regucalcin [41]. Overexpression of regucalcin in H4-II-E
cells suppresses DNA fragmentation enhanced by Bay K
8644. Regucalcin has a suppressive effect on Ca2? entry-
mediated cell death due to depressing rise in intracellular
Ca2? concentration in hepatoma cells. In addition, regu-
calcin may suppresse effect of Ca2? on DNA fragmenta-
tion in the nucleus of H4-II-E cells.
Regucalcin suppresses insulin or insulin growth factor-I
(IGF-I)-induced apoptosis
The effect of insulin or IGF-I on cell death and apoptosis in
H4-II-E cells has been not known. H4-II-E cells were
cultured in a medium containing, either vehicle, insulin,
IGF-I, epinephrine, or transforming growth factor-b (TGF-
b) in absence of FBS [50]. The number of wild-type cells
was decreased after culture of insulin or IGF-I [50]. Aga-
rose gel electrophoresis showed presence of low-molecu-
lar-weight DNA fragments of adherent wild-type cells
cultured in the presene of insulin or IGF-I [36]. The effect
of insulin or IGF-I in stimulating cell death and DNA
fragmentation H4-II-E cells was suppressed by overex-
pression of regucalcin [50].
The effect of insulin in decreasing the number of H4-II-
E cells is protected in presence of caspase-3 inhibitor [50].
The effect of IGF-I on cell death, however, is observed in
presence of caspase-3 inhibitor [50]. These observations
suggest that the effect of insulin on cell death is involved in
activation of caspase-3 and that effect of IGF-I is not
dependent on caspase-3 in H4-II-E cells. The effect of IGF-
I in inducing cell death in presence of caspase-3 inhibitor
was completely suppressed by overexpression of regucal-
cin [50]. Regucalcin may depress signaling pathway of
IGF-I-induced cell death, which is not mediated through
caspase-3 in H4-II-E cells.
The effect of insulin or IGF-I in inducing cell death and
apoptosis of H4-II-E cells is depressed in presence of
N-nitro-L-arginine methylester (NAME), an inhibitor of
NO synthase [50], suggesting that insulin- or IGF-induced
cell death is partly involved in production of NO in H4-II-E
cells. Overexpression of regucalcin has been shown to have
a suppressive effect on activation of Ca2?/calmodulin-
dependent NO synthase in H4-II-E cells [31].
The effect of IGF-I in inducing apoptosis of H4-II-E
cells has been shown to reveal in presence of Bay K 8644
[50]. This effect is not seen in the case of insulin [50]. The
mode of IGF-I action differs from that of insulin. It is
assumed that insulin induces cell death, which is partly
mediated through intracellular Ca2?-dependent signaling
pathway in H4-II-E cells, and that IGF-I may be not me-
diathed through Ca2?-dependent signaling pathway in H4-
II-E cells. The effect of IGF-I in inducing cell death in
presence of Bay K 8644 was suppressed by overexpression
of regucalcin [50].
Genistein has an inhibitory effect on protein tyrosine
kinases and produces cell cycle arrest and apoptosis in
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leukemic cells [51]. Genistein was found to induce cell
death of H4-II-E cells, and such effect was not seen by
overexpression of regucalcin [51]. Genistein-induced cell
death is partly mediated through inhibition of protein
tyrosine kinase in H4-II-E cells. Regucalcin has an inhib-
itory effect on protein tyrosine kinase activity in the
cytoplasm and nucleus of rat liver [52].
The effect of insulin in inducing cell death of H4-II-E
cells was suppressed in presence of genistein [50], although
this effect was not seen in case of IGF-I. The effect of
IGF-I on cell death in presence of genistein was protected in
the transfectants overexpressing regucalcin [50]. Regucalcin
has a suppressive effect on cell apoptosis that is mediated
through signaling pathways with dependent or independent
on protein tyrosine kinase.
Vanadate is an inhibitor of protein tyrosine phosphatase
in cells [53]. Regucalcin has been shown to have an
inhibitory effect on protein tyrosine phosphatase activity in
the cytoplasm and nucleus of rat liver [54]. Vanadate
induced apoptosis of H4-II-E cells [50], suggesting that cell
death is not involved in mechanism that is mediated
through inhibition of protein tyrosine phosphatase activity.
Vanadate induced cell death of transfectants overexpress-
ing regucalcin [50], suggesting that suppressive effect of
regucalcin on cell death of H4-II-E cells is independent on
protein phosphatase. IGF-I stimulated cell death of H4-II-E
cells overexpressing regucalcin in presence of vanadate
[50], suggesting that effect of IGF-I is not mediated
through protein tyrosine phosphatase in transfectants.
Thus, the effect of insulin in inducing apoptosis may be
partly mediated through signaling pathway which is
involved in caspase-3, Ca2?, NO, protein tyrosine kinase,
or protein tyrosine phosphatase in H4-II-E cells. The effect
of IGF-I on apoptosis of H4-II-E cells may be mediated
through NO and other molecules. Overexpression of reg-
ucalcin may have a suppressive effect on signaling path-
ways which insulin or IGF-I induces cell death of H4-II-E
cells.
Regucalcin suppresses sulforaphane-induced apoptosis
Sulforaphane is an isothiocyanate that is present naturally
in widely consumed vegetables and has a particularly high
concentration in broccoli. This compound has been shown
to block the formation of tumors initiated by chemicals in
the rat [55]. Sulforaphane induces a cell cycle arrest, fol-
lowed by cell death in HT29 human colon cancer cells
[55]. Sulforaphane increases expression of the pro-apop-
totic protein Bax, the release of cytochrome C from the
mitochondria to the cytosol, and proteolytic cleavage of
poly (ADP-ribose) polymerase in HT29 human colon
cancer cells [55]. In human T cell leukemia, sulforaphane
induces apoptosis due to increasing p53 and Bax protein
expressions and slightly affecting Bcl-2 expression [56]. In
cultured PC-3 human prostate cancer cells, sulforaphane-
induced apoptosis is associated with up-regulation of Bax,
down-regulation of Bcl-2 and activation of caspase-3, -9,
and -8 [57]. Sulforaphane induced cell death and apoptosis
in H4-II-E cells [58]. The effect of sulforaphane on apop-
tosis was depressed caspase-3 inhibitor, while it was not
inhibited by NAME, an inhibitor of NO synthase, in H4-II-
E cells [58]. Sulforaphane-induced cell death and apoptosis
partly result from activation of caspase-3 in hepatoma
cells. Overexpression of regucalcin was found to have
suppressive effects on cell death and apoptosis induced by
sulforaphane in H4-II-E cells [58]. This effect of regucalcin
may be partly involved in the molecules of Bax, cyto-
chrome C, caspase, and Bcl-2. In addition, regucalcin may
have an inhibitory effect on NO synthase and Ca2?-
dependent endonuclease activities in H4-II-E cells [24, 31].
As described above, regucalcin has been shown to have
suppressive effects on cell death and apoptosis in H4-II-E
cells, which are mediated through various signaling factors
[36, 41, 50]. Regucalcin may have a suppressive effect on
various signaling pathways that mediate apoptotic cell
death. Overexpression of regucalcin has suppressive effects
on cell death and apoptosis induced by TNF-a, LPS,
thapsigargin, Bay K 8644, dibucaine, or PD98059, an
inhibitor of protein thyrosine kinase, insulin, IGF-I, or
sulforaphane in H4-II-E cells [36, 41, 50]. Signaling
mechanisms that TNF-a, LPS, or other factors mediate cell
death and apoptosis may be different. Suppressive effect of
regucalcin on apoptotic cell death is related to its inhibitory
effect on the activities of various protein kinases, NO
synthase, caspase-3, or Ca2?-dependent endonuclease, and
its activatory effect on Bcl-2. Regucalcin has suppressive
effects on various signaling-mediated cell death and
apoptosis and suppresses cell death and apoptosis mediated
through various different signaling pathways in H4-II-E
cells.
Regucalcin rescues apoptosis in normal kidney cells
Regucalcin has been shown to express in the cloned normal
rat kidney proximal tubular epithelial NRK52E cells and its
expression is increased after hormonal stimulation [59].
The nuclear localization of regucalcin is enhanced after
hormone stimulation in NRK52E cells [60]. NRK52E cells
(transfectants) overexpressing endogenous regucalcin have
been generated. Regucalcin content in this transfectants
showed about 21-fold as compared with that of the parental
wild-type cells. Enhancement of cell proliferation was
suppressed in the transfectants overexpressing regucalcin
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[61]. The number of wild-type cells was decreased after
culture for 42–72 h in presence of TNF-a, TGF-b, LPS,
Bay K 8644, or thapsigargin [62, 63]. This effect was not
seen in the transfectants overexpressing regucalcin. DNA
fragmentation induced after culture with LPS, Bay K 8644,
or thapsigargin were protected in the transfectants over-
expressing regucalcin [62]. Thus, overexpression of regu-
calcin has been found to have a suppressive effect on
apoptotic cell death induced by TNF-a, TGF-b, LPS, Bay
K 8644, or thapsigargin in NRK52E cells. The effect of
regucalcin in suppressing apoptotic cell death may be
mediated through its action on various signaling pathways
in NRK52E cells.
Overexpreesion of regucalcin has been found to enhance
the gene expressions of NF-jB or Smad2, which is sig-
naling factor of TNF-a or TGF-b, in NRK52E cells [63].
However, stimulatory effect of TNF-a or TGF-b on Smad2
and NF-jB mRNA expressions was not significantly
enhanced in transfectants [63]. This suggests that sup-
pressive effects of regucalcin on TNF-a- or TGF-b-induced
apoptosis may not be based on NF-jB and Smad2 mRNA
expressions. Suppressive effect of regucalcin on apoptosis
may be related to its action on other signaling pathways.
Bcl-2 is a suppressor in apoptotic cell death [64]. Apaf-1
participates in activation of caspase-3 [65]. Akt-1 regulates
survival-signaling pathways in cell death [66]. Overex-
pression of regucalcin caused a remarkable elevation of
Bcl-2 mRNA expression in NRK52E cells, and it slightly
stimulated Akt-1 mRNA expression in the cells. Apaf-1,
caspase-3, or G3PDH mRNA expressions were not sig-
nificantly altered in transfectants [67]. Presumably, the
enhancement of Bcl-2 mRNA expression contributes to
rescue of apoptotic cell death in NRK52E cells over-
expressing regucalcin. Regucalcin may play a role in reg-
ulation of Bcl-2 gene expression in NRK52E cells.
TNF-a enhanced expression of caspase-3 mRNA in
NRK52E cells [62]. This effect was depressed in trans-
fectants [62], suggesting that the mechanism by which
regucalcin suppresses TNF-a-induced cell death is partly
related to suppression in caspase-3 mRNA expression in
transfectants.
Culture with LPS caused a significant decrease in Bcl-2
mRNA expression in NRK52E cells, suggesting that this
decrease is partly related to LPS-induced cell death [62].
Enhancement of Bcl-2 mRNA expression caused by
overexpression of regucalcin was also seen in presence of
LPS [62]. LPS-stimulated expression of Apaf-1 mRNA
was suppressed after overexpression of regucalcin [62].
This may partly involve in suppression of LPS-induced cell
death in NRK52E cells overexpressing regucalcin.
Culture with Bay K 8644 or thapsigargin has been
shown to cause an increase in caspase-3 mRNA expression
in wild-type cells, indicating that increased gene expression
partly contributes to inducing apoptotic cell death [62].
This enhancement was completely depressed in transfec-
tants. Regucalcin may have a suppressive effect on cas-
pase-3 mRNA expression enhanced after culture with Bay
K 8644 or thapsigargin in NRK52E cells. Thus, regucalcin
regulates expression of Bcl-2, caspase-3, and Akt-1
mRNAs in NRK52E cells. Change in these proteins level,
however, remains to be elucidated.
Overexpression of regucalcin has a suppressive effect on
apoptotic cell death induced by various factors (including
TNF-a, TGF-b, LPS, Bay K 8644, or thapsigargin) in
NRK52E cells. Toxic factors have been reported to induce
renal failure due to stimulating apoptotic cell death [67].
Regucalcin may play a role as a suppressor in inducing of
apoptotic cell death in kidney proximal tubular epithelial
cells.
Prospect
Overexpression of regucalcin rescues cell death and
apoptosis induced with various factors (including TNF-a,
TGF-b, LPS, insulin, IGF-I, Bay K 8644, PD98059, dib-
ucaine, thapsigargin, or sulphoraphan), which those sig-
naling mechanisms are different in the hepatoma cells and
normal kidney cells. The anti-apoptotic effect of regucalcin
is mediated through suppressive effects on various signal-
ing pathways that mediate apoptotic cell death as sum-
marized in Fig. 1. This effect of regucalcin is based on
inhibitory effects on the activities of NO synthase, protein
kinase, protein phosphatase, caspase-3, or Ca2?-dependent
endonuclease and stimulatory effects on Bcl-2 and Akt-1
mRNA expressions. Caspase-3, which is final stage of
apoptosis-inducing signaling pathways, activates nuclear
endonuclease. This enzyme plays a pivotal role in nuclear
DNA fragmentation. Moreover, regucalcin, which is
translocated into the nucleus, has been shown to directly
suppress endonuclease. This suppression may play a piv-
otal role as molecular mechanism by which regucalcin
rescues apoptotic cell daeth that is mediated through var-
ious signaling factors. Regucalcin has been shown to sup-
press cell proliferation [68]. The anti-apoptotic effect of
regucalcin may not be related to suppression of cell pro-
liferation. Regucalcin may be important as a molecule to
protect cells from apoptosis. Although physiological sig-
nificance of the anti-apoptotic effect of regucalcin remains
to be elucidated, regucalcin may play a pivotal role as a
regulatory protein in signaling systems in maintaining of
cell homeostasis. Targeting of regucalcin molecule may be
an important in protection of cell death that is evoked in
various pathophysiologica states.
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